Jump to content

Drilldown: Medicines

Choose a table:


Medicines > routes: Subcutaneous & onset: Over weeks & pregnancy: Limited data; avoid

Use the filters below to narrow your results.

generic:
None (2)
brand:
Ajovy (1) · Emgality (1)
classes:
Anti-CGRP ligand monoclonal antibody (2)
mechanism:
Humanized IgG2 monoclonal antibody binding both isoforms of CGRP peptide (1) · Humanized IgG4 monoclonal antibody binding CGRP peptide; prevents CGRP from activating its receptor (1)
uses:
Preventive treatment of migraine in adults (episodic and chronic) (1) · Preventive treatment of migraine in adults; episodic cluster headache (1)
starting dose:
225 mg SC monthly, or 675 mg SC every 3 months (quarterly) (1) · Migraine: 240 mg SC loading dose, then 120 mg SC monthly. Cluster: 300 mg SC at onset of cluster period, then monthly during cluster. (1)
preparations:
120 mg/mL prefilled syringe or autoinjector (1) · 225 mg/1.5 mL prefilled syringe or autoinjector (1)
fda max:
240 mg loading + 120 mg/month for migraine; 300 mg/month for cluster (1) · 675 mg/quarter (1)
routes: (Click arrow to add another value)
onset: (Click arrow to add another value)
duration:
Monthly dosing (1) · Monthly or quarterly dosing (1)
halflife:
~27 days (1) · ~31 days (1)
bioavailability:
Not formally established (1) · Not formally established (high SC) (1)
pregnancy: (Click arrow to add another value)
legal:
Rx (2)

Showing below up to 2 results in range #1 to #2.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"